Zelnorm

ZelnormZelnorm (also Zelmac) is the brand name for the pharmaceutical product Tegaserod, marketed by Novartis as a remedy for irritable bowel syndrome (IBS) and constipation. Zelnorm was introduced to the U.S. market in 2002, subsequent to Food and Drug Administration (FDA) approval.

In 2007, the FDA asked Novartis to take Zelnorm off the market, based on an analysis of data by the agency. After receiving reports that Zelnorm might be tied to increased risk of stroke or heart attack, the FDA reviewed data from more than 18,000 patients. The study showed that the incidences of cardiovascular problems of people who took Zelnorm was more than 10 times the rate of those who took a placebo.

If you or someone you love has suffered injury after being prescribed Zelnorm, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

    Latest Article

      GETLEGAL®ATTORNEY DIRECTORY

      Find Leading Attorneys in Your Area

          NEED PROFESSIONAL HELP?

          Talk to an Attorney

          How It Works

          • Briefly tell us about your case
          • Provide your contact information
          • Choose attorneys to contact you

          About GetLegal

          Our mission at GetLegal is to develop a family of sites that constitute the most useful, informative, reliable and exciting collection of legal resources on the web. We are constantly working to expand and improve many resources we offer to legal professionals and the public.

          List Your Law Firm in the GetLegal Attorney Directory
          Advertise With Us
          Newsletter Sign-Up

          By submitting information to this site, you give permission to GetLegal, or a partner of GetLegal, to contact you by email.

          © 2008-2022 LawConnect, Inc. All rights reserved. Sitemap | Copyright/DMCA Policy | Privacy Policy | Terms of Use | Disclosures/Disclaimers